Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Institute of Pharmacology & Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Br J Pharmacol. 2022 Jan;179(1):3-22. doi: 10.1111/bph.15692. Epub 2021 Nov 9.
Epilepsy is a common neurological disorder characterized by repeated and spontaneous epileptic seizures and is not well controlled by current medication. Traditional theory suggests that epilepsy results from an imbalance of excitatory glutamate neurons and inhibitory GABAergic neurons. However, new evidence from clinical and preclinical research suggests that histamine in the CNS plays an important role in the modulation of neural excitability and in the pathogenesis of epilepsy. Many histamine receptor ligands have achieved curative effects in animal epilepsy models, among which the histamine H receptor antagonist pitolisant has shown anti-epileptic effects in clinical trials. Recent studies, therefore, have focused on the potential action of histamine receptors to control and treat epilepsy. In this review, we summarize the findings from animal and clinical epilepsy research on the role of brain histamine and its receptors. We also identify current gaps in the research and suggest where further studies are most needed.
癫痫是一种常见的神经系统疾病,其特征是反复发作和自发性癫痫发作,目前的药物治疗效果不佳。传统理论认为,癫痫是由于兴奋性谷氨酸神经元和抑制性 GABA 能神经元之间的失衡引起的。然而,来自临床和临床前研究的新证据表明,中枢神经系统中的组胺在调节神经兴奋性和癫痫发病机制中发挥重要作用。许多组胺受体配体在动物癫痫模型中已取得疗效,其中组胺 H 受体拮抗剂吡咯利生在临床试验中显示出抗癫痫作用。因此,最近的研究集中在组胺受体的潜在作用,以控制和治疗癫痫。在这篇综述中,我们总结了关于脑组胺及其受体在动物和临床癫痫研究中的作用的发现。我们还确定了研究中的现有差距,并建议最需要进一步研究的地方。